High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

Item
http://www.wikidata.org/entity/Q28547703
GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsSecond line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspectiveDiagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern ThailandDelamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance.Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis.Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.Performance of the Abbott RealTime MTB and MTB RIF/INH Assays in a Setting of High Tuberculosis and HIV Coinfection in South Africa.Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South AfricaBenefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.Rapid Microarray-based Detection of Rifampicin-, Isoniazid- and Fluoroquinolone Resistance in Mycobacterium tuberculosis using a Single Cartridge.Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosis
P2860

High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

Item
http://www.wikidata.org/entity/Q28547703
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@ast
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@en
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@nl
type
label
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@ast
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@en
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@nl
prefLabel
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@ast
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@en
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
High Prevalence of inhA Promot ...... in KwaZulu-Natal, South Africa
@en
P2093
P2860
P304
P31
P3181
P356
10.1371/JOURNAL.PONE.0135003
P407
P433
P478
P50
P577
P5875
P698
P921
P932